Topical testosterone formulations and associated methods

   
   

A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.

Se divulga una formulación tópica de la testosterona. En un aspecto, la formulación puede incluir una cantidad terapéutico eficaz de testosterona micronized, de un ingrediente del arginine, y de un ingrediente del tocopherol mezclado con un organogel de la lecitina del poloxamer. Los ingredientes adicionales pueden ser incluidos, por ejemplo melatonin, oxytocin, DHEA, y progesterona.

 
Web www.patentalert.com

< Hybrid carnation plant named `CFPC SARI`

< Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery

> Character input interface for compact electronic devices

> Antihelminthic anthraquinones and method of use thereof

~ 00115